ASBMB Annual Meeting

Kountz tracks methyls in microbe metabolism

Meet a JBC Herbert Tabor Early Career Investigator Award winner
Courtney Chandler
March 12, 2021

Duncan Kountz became interested in microbial biochemistry through a seemingly standard source: a textbook. But this wasn't a textbook assigned for class or research — he chose it himself because it seemed interesting, a habit he started in high school.

Kountz-430x430.jpg
Duncan Kountz

"Textbooks help me expand what I'm exposed to," Kountz said, "and I find them perfectly tolerable as long as they're on a subject I'm interested in."

The habit helped him prepare for a career in science, which he knew he wanted to pursue from the time he was in high school. Following a family legacy, he attended Ohio State University and sought research opportunities. He started out in a developmental biology lab, but that textbook, "The Physiology and Biochemistry of Prokaryotes," inspired a move to microbial metabolism. He contacted Joseph Krzycki, an OSU researcher in the field, and joined Krzycki's lab as a sophomore.

"Complexity and diversity really interest me, and I found that in microbial physiology, those are both on display," Kountz said. "Microbes may seem like they're a simple system, but they're also amenable to detailed work."

The Krzycki lab was finishing a project on an enzyme belonging to a superfamily of methyltransferases, and Kountz wanted to investigate similar enzymes in the context of the gut microbiome. He observed that a particular gut bacterium, Eubacterium limosum, encoded many of these enzymes and could utilize several unusual molecules for its growth. He focused on one in particular, carnitine, and tracked down the enzymes responsible for its metabolism.

His research shows how microbial metabolism can affect both microbial prosperity and the health of the human host, as carnitine metabolism can produce toxic byproducts. Kountz was excited about the findings, in part for this potential real-world applicability.

"I think we are really at the dawn of using microbes to solve problems," he said. "I'm excited about the idea of engineering or finding new microbes with interesting properties that we can exploit to make human life better."

Now a fourth-year Ph.D. student in Emily Balskus' lab at Harvard, Kountz said his textbook count currently exceeds 100.

Methyl-removing enzyme diverts toxin precursor

Gut bacteria can produce harmful compounds as a byproduct of their normal metabolism. Carnitine, a quaternary amine found abundantly in red meat, can lead to production of a toxin precursor called trimethylamine, or TMA, during digestion. TMA is converted in the liver to TMA oxide, a marker of cardiovascular disease.

Duncan Kountz and colleagues at Ohio State showed that the gut bacteria Eubacterium limosum can use carnitine as fuel, thereby potentially curbing TMA production. They also identified a new metabolite, called norcarnitine, produced by demethylation of carnitine.

Seeking to identify the enzymes involved in this metabolic transformation, Kountz noticed that E. limosum encoded many enzymes in the MttB superfamily. MttB proteins are involved in methyl transfer reactions.

Kountz characterized the enzymes involved in this pathway and identified a methyltransferase, MtcB, that demethylates carnitine and shuttles the product into pathways responsible for energy utilization and biogenesis.

The study highlights how metabolic activities in gut microbia may promote health by preventing production of toxin precursors.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Courtney Chandler

Courtney Chandler is a biochemist and microbiologist in Baltimore, Md., and a columnist for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Uncovering the molecular roots of fatty liver disease
Interview

Uncovering the molecular roots of fatty liver disease

June 3, 2026

Physician–scientist Silvia Sookoian discusses her path from hepatitis C care to MASLD research, her use of multi-omics to study steatotic liver disease, and how lipid metabolism and genetics are reshaping understanding of MASH and liver health.

Kimble honored for lifetime achievement in genetics
Member News

Kimble honored for lifetime achievement in genetics

June 1, 2026

She received the 2026 Thomas Hunt Morgan Medal and will be honored with a dedicated online profile and seminar.

Janetka named distinguished professor
Member News

Janetka named distinguished professor

June 1, 2026

Washington University awarded him the inaugural Carl Frieden Distinguished Professorship.

ASBMB members receive ASPET awards
Member News

ASBMB members receive ASPET awards

May 25, 2026

The American Society for Pharmacology and Experimental Therapeutics awards Simone Brixius–Anderko, Paul Insel, Sudarshan Rajagopal, Emily Scott, Alan Smrcka and Jürgen Wess for their excellent research and mentoring work in pharmacology.

Kozul honored by Washington University
Member News

Kozul honored by Washington University

May 25, 2026

She received the 2025 Elliot L. Elson Education and Training Award.

de la Fuente honored for AI research
Member News

de la Fuente honored for AI research

May 18, 2026

The award will support the development of an AI system called ApexMol, a 3D structure–informed, agentic large language model designed to create new biomolecules.